Binding Properties of β-Blockers at Recombinant β1-, β2-, and β3-Adrenoceptors
Authors:
- Petra SchnabelPSPetra Schnabel
- Christoph MaackCMChristoph Maack
- Florian MiesFMFlorian Mies
- Stephan TyrollerSTStephan Tyroller
- Alexander ScheerASAlexander Scheer
- Michael BöhmMBMichael Böhm
- 1 October 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 36 (4) , 466-471
Abstract
The human heart contains at least four distinct beta-adrenoceptor subtypes, three of which have been cloned. However, the binding properties of beta-blockers to the different beta-adrenoceptor subpopulations are not yet thoroughly characterized. Human beta1-, beta2- and beta3-adrenoceptors were expressed in COS-7 cells and [125I]iodocyanopindolol saturation binding, and competition experiments with commonly used beta-blockers were performed in the respective membrane preparations. Atenolol and metoprolol were about fivefold selective for beta1- versus beta2- and beta3-adrenoceptors. Bisoprolol was approximately 15-fold selective for beta1- versus beta2- and approximately 31-fold selective for beta1- versus beta3-adrenoceptors. Carvedilol was nonselective for any beta-adrenoceptor subtype. We conclude that the beta1-selectivities of atenolol, metoprolol, and bisoprolol are lower in COS cell membranes compared with previous investigations performed in native membranes. All beta-blockers investigated bind to beta3-adrenoceptors. Differential binding properties to beta3-adrenoceptors might imply different responses as to body weight, cardiac contractility, heart rate, and growth regulation. This might imply differential indications for the drugs investigated.Keywords
This publication has 15 references indexed in Scilit:
- The Molecular Basis for Distinct β-Adrenergic Receptor Subtype Actions in CardiomyocytesCirculation Research, 1999
- Recent Advances in Cardiac β2-Adrenergic Signal TransductionCirculation Research, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Coupling of β2-Adrenoceptor to GiProteins and Its Physiological Relevance in Murine Cardiac MyocytesCirculation Research, 1999
- β-Adrenergic signal transduction in the failing and hypertrophied myocardiumJournal of Molecular Medicine, 1997
- STRUCTURE AND FUNCTION OF THE β3-ADRENERGIC RECEPTORAnnual Review of Pharmacology and Toxicology, 1997
- Four β-adrenoceptor subtypes in the mammalian heartTrends in Pharmacological Sciences, 1997
- Functional beta3-adrenoceptor in the human heart.Journal of Clinical Investigation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Cardiac adrenergic receptor effects of carvedilolEuropean Heart Journal, 1996